TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-09.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 · last filed 2022-02-09
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2020 was $259.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-09 |
| 2020-12-31 | $259.00M 10-K · filed 2022-02-09 |